Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| AIRO Group Holdings, Inc.AIRO · Entity 6200 | Director | June 04, 2026 | June 05, 2026 |
| Ocean Biomedical, Inc.OCEA · Entity 8695 | Director · Chief Executive Officer | February 14, 2023 | February 17, 2023 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
AIRO Group Holdings, Inc.
Report date June 04, 2026 · Filed June 05, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 15,486 |
Reported balance
After 2026-06-04 transaction · row 1
1 source rowRow 1 · 2026-06-04 · Grant · Acquired 11,026 · Balance 15,486 F1: Represents the grant of restricted stock units ("RSUs"), each of which represents a contingent right to receive one share of the Issuer's common stock. The RSUs will vest in full on the earlier of (i) June 4, 2027 or (ii) the date of the Issuer's next annual stockholder meeting (or the date immediately prior to the Issuer's next annual stockholder meeting if the Reporting Person's service as a director ends at such meeting due to the Reporting Person's failure to be re-elected or the Reporting Person not standing for re-election). |
Filing footnotes · ownership attribution and instrument terms
F1: Represents the grant of restricted stock units ("RSUs"), each of which represents a contingent right to receive one share of the Issuer's common stock. The RSUs will vest in full on the earlier of (i) June 4, 2027 or (ii) the date of the Issuer's next annual stockholder meeting (or the date immediately prior to the Issuer's next annual stockholder meeting if the Reporting Person's service as a director ends at such meeting due to the Reporting Person's failure to be re-elected or the Reporting Person not standing for re-election).
Ocean Biomedical, Inc.
Report date February 14, 2023 · Filed February 17, 2023
This filing explicitly reported no securities owned.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| June 04, 2026 Filed Jun 5, 2026 20:30 UTC | AIRO Group Holdings, Inc. AIRO · Entity 6200 | GrantCommon Stock | 11,026 | $0.00 | $0.00 |
DisclosureSEC source: 0001873974-26-000004 · form4-06052026_040603.xml · nonDerivative · entry 1 Ng Elizabeth · CIK 0001873974 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 15,486 F1 · shares: Represents the grant of restricted stock units ("RSUs"), each of which represents a contingent right to receive one share of the Issuer's common stock. The RSUs will vest in full on the earlier of (i) June 4, 2027 or (ii) the date of the Issuer's next annual stockholder meeting (or the date immediately prior to the Issuer's next annual stockholder meeting if the Reporting Person's service as a director ends at such meeting due to the Reporting Person's failure to be re-elected or the Reporting Person not standing for re-election). Read SEC document |
| February 01, 2026 Filed Feb 5, 2026 21:30 UTC | AIRO Group Holdings, Inc. AIRO · Entity 6200 | GrantCommon Stock | 4,460 | $0.00 | $0.00 |
DisclosureSEC source: 0001873974-26-000002 · form4-02052026_040203.xml · nonDerivative · entry 1 Ng Elizabeth · CIK 0001873974 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4,460 F1 · shares: Represents the grant of restricted stock units ("RSUs"), each of which represents a contingent right to receive one share of the Issuer's common stock. The RSUs will vest in full on the date of the next annual meeting of the Issuer's stockholders, subject to the Reporting Person's continuous service with the Issuer through such date. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.